CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors

BACKGROUND: To validate the utility of the chemokine ligand 12 (CXCL12) as prognostic marker in patients with localized and metastatic germ cell tumors (GCT). METHODS: CXCL12 expression was analyzed on a tissue microarray consisting of 750 tissue cores of different histological tumor components, Ger...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Fankhauser, Christian Daniel, Roth, Lisa, Grossmann, Nico Christian, Kranzbühler, Benedikt, Eberli, Daniel, Sulser, Tullio, Moch, Holger, Bode, Peter-Karl, Beyer, Joerg, Hermanns, Thomas
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693197/
https://ncbi.nlm.nih.gov/pubmed/31412792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5961-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky